Financial Profile
  
   
UNAUDITED FINANCIAL RESULTS
FOR THE QUARTER ENDED 30TH SEPTEMBER, 2002
  
Rs in millions
--
Quater Ended
Half Year Ended
Year Ended
30.09.2002
30.09.2001
30.09.2002
30.09.2001
31.03.2002
(Audited)
1
Net Sales & Income from Operations
3943.4
3410.6
7972.9
6402.4
14005.1
2
Other Income
40.9
79.2
88.7
127.5
283.6
3
Total Expenditure
.
.
.
.
.
    
a) (Increase) / decrease in Stock-in -trade
11.6
100.9
(201.2)
(46.6)
(850.9)
   
b) Consumption of  Materials
1793.1
1468.3
3771.9
3006.0
6907.5
c) Staff Cost
158.4
149.2
355.2
303.4
632.5
d) Other Expenditure
998.9
934.9
2242.9
1796.6
4272.1
4
Interest
1.7
4.7
4.0
7.2
21.0
5
Depreciation
67.5
47.5
137.5
95.0
212.8
6
Profit (+) / Loss (-) before Tax (1+2-3-4-5)
953.1
784.3
1751.3
1368.3
3093.7
7
Provision for Taxation
216.5
180.0
408.4
320.0
742.5
8
Net Profit (+) / Loss (-) after tax
(6-7)
736.6
604.3
1342.9
1048.3
2351.2
9
Paid-up Equity Share Capital
599.7
599.7
599.7
599.7
599.7
10
Reserves excluding
Revaluation Reserves
(as per balance-sheet of previous accounting year)
        
8197.0
11
Earning per Share
* Not Annualised
*12.28
*10.08
*22.39
*17.48
34.62
12

Aggregate of Non-Promoter Shareholding
- Number of Shares
- Percentage of Shareholding


36044237
60.10


35843463
59.77


36044237
60.10



35843463
59.77


36044037
60.10
Notes:
1
Provision for tax includes deferred taxation
2
The Company is exclusively in the pharmaceutical business segment
3
The figures of the previous year have been regrouped to render them comparable with the figures of the current year.
4
The above results were taken on record at the meeting of the Board of Directors held on 22nd October, 2002.
By order of the Board
For CIPLA LIMITED
   

Mumbai
22nd October, 2002.
Dr. Y. K. Hamied
Chairman & Managing Director